BeOne Medicines detailed its oncology pipeline, highlighting BRUKINSA, sonrotoclax, and BGB-16673 for various patient populations.
1 report, 0 independent
Updated Jun 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
BeOne Medicines detailed its oncology pipeline, highlighting BRUKINSA, sonrotoclax, and BGB-16673 for various patient populations.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
BeOne Medicines (Switzerland)
company in Basel, Switzerland
Nothing else this week.
Coverage
Newest first; wire copies grouped- Unknown outlet